V2 Cloud sunsets August 10, 2026. Own TexAu on your machine.

Founder price $1,499 one-time — unlimited hours, no proxies, runs locally. Ends June 10, 2026. Pre-order V2 Desktop →

Back to profiles
BillionToOne logo

BillionToOne

BillionToOne, founded in 2015 in San Francisco, California, is a unicorn genomics company developing cell-free liquid biopsy tests for cancer and genetic disorders. The company has raised a total of $389M, including a $130M Series D on June 21, 2024, led by Premji Invest, reaching a $1B valuation. With investors such as Baillie Gifford and Premji Invest, BillionToOne leverages its proprietary molecular counter platform to advance precision diagnostics, expand oncology testing, and make molecular testing more accessible globally.